Subcutaneous Rituximab-MiniCHOP ± Lenalidomide in Older Patients With DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older
J. Clin. Oncol 2021 Jan 14;[EPub Ahead of Print], L Oberic, F Peyrade, M Puyade, C Bonnet, P Dartigues-Cuillères, B Fabiani, P Ruminy, H Maisonneuve, J Abraham, C Thieblemont, P Feugier, G Salles, F Bijou, GM Pica, G Damaj, C Haioun, RO Casasnovas, H Farhat, R Le Calloch, A Waultier-Rascalou, S Malak, J Paget, E Gat, H Tilly, F JardinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.